Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 767 Lymphoma 713 Leukemia, Lymphocytic, Chronic, B-Cell 560 Lymphoma, Follicular 515 Lymphoma, Large B-Cell, Diffuse 440 Precursor Cell Lymphoblastic Leukemia-Lymphoma 331 Recurrence 317 Lymphoma, B-Cell 294 Neoplasms 261 Lymphoma, Mantle-Cell 251 Leukemia 231 Multiple Myeloma 189 Hodgkin Disease 179 Leukemia, Myeloid, Acute 178 Lymphoma, B-Cell, Marginal Zone 135 Lymphoma, T-Cell, Peripheral 119 Burkitt Lymphoma 105 Myelodysplastic Syndromes 101 Hematologic Neoplasms 100 Lymphoma, T-Cell, Cutaneous 88 Waldenstrom Macroglobulinemia 84 Leukemia, B-Cell 79 Lymphoma, T-Cell 74 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65 Lymphoproliferative Disorders 57 Hematologic Diseases 57 Melanoma 54 Carcinoma, Non-Small-Cell Lung 54 Breast Neoplasms 51 Mycosis Fungoides 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Large B-cell Lymphoma × Lymphoid × Clear all

NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡